Maria Georgiadou

Dr. Maria Georgiadou

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ATArgyrios Tzamalis
Argyrios Tzamalis
MFMaria Foti
Maria Foti
MGMaria Georgiadou
Maria Georgiadou
NTNikolaos Tsaftaridis
Nikolaos Tsaftaridis
NZNikolaos Ziakas
Nikolaos Ziakas
Background/Objectives: To provide insight into populations at higher risk of COVID-19-related retinal vascular occlusion, we identified the baseline characteristics of COVID-19 patients and vaccine recipients who developed this condition by conducting a systematic review to summarize the findings and evaluate the current knowledge on this subject. Methods: An electronic search on the PubMed and Scopus databases was performed for relevant case reports or series regarding retinal vascular occlusion in patients with past or present COVID-19 infection or SARS-CoV-2 immunization. This study was conducted using a pre-determined protocol following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 34 studies were enrolled in this systematic review. A total of 21 patients (14 males, 66.7%) have been diagnosed with COVID-19 related retinal vein occlusion (RVO, mean age = 41.9 ± 10.3 years), and 15 patients (12 males, 80%) have been diagnosed with retinal artery occlusion (RAO, mean age = 56.9 ± 13.2 years). The time to RVO since COVID-19 infection or SARS-CoV-2 immunization ranged from 8 h to 51 days (mean = 12.3 ± 15.7 days), while the time to RAO ranged from 2 to 40 days (mean = 14.9 ± 10.8 days). Fifteen out of the twenty-one patients (71.4%) with RVO had a significant improvement in visual acuity after the resolution of symptoms while eight out of the fifteen patients (53.3%) with RAO did not show improvement. Conclusions: COVID-19 seems to play a significant role in the pathogenesis of vascular occlusion, as it is suggested to increase the risk of thromboembolic episodes. However, the pathophysiologic mechanisms have not been fully elucidated, and further studies are expected to shed light on this phenomenon.

1 February 2026 in Brain Hemorrhages
Verified
Journal Article
Open access
Theofilos KanavosTheofilos Kanavos
Theofilos Kanavos
Effrosyni BirbasEffrosyni Birbas
Effrosyni Birbas
MGMaria Georgiadou
Maria Georgiadou
NTNikolaos Tsaftaridis
Nikolaos Tsaftaridis

7 October 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Open access
PDF file
MGMaria Georgiadou
Maria Georgiadou
Theofilos KanavosTheofilos Kanavos
Theofilos Kanavos
Effrosyni BirbasEffrosyni Birbas
Effrosyni Birbas
MMMaria Marinakis
Maria Marinakis
NTNikolaos Tsaftaridis
Nikolaos Tsaftaridis
Background: Cardiac surgery carries a disproportionately elevated risk of perioperative ophthalmological complications compared with other surgical procedures. Despite growing recognition of ocular and visual complications in this setting, a comprehensive synthesis of their entire spectrum has been lacking. Objective: To systematically identify, map, and characterize the full range of ocular and visual complications reported following cardiac surgery, including disorders affecting ophthalmic structures, ocular motility, or visual function. Methods: This scoping review was conducted following the Joanna Briggs Institute methodology and reported according to the PRISMA-ScR recommendations. PubMed, Embase, and Web of Science were searched from inception through January 2025 for studies reporting ocular or visual complications directly associated with heart or great vessel surgery. Evidence was charted by complication type and synthesized descriptively. Results: Our review included 115 studies, mostly case reports. The most frequently reported complications were ischemic optic neuropathy, retinal vascular occlusive disorders, cerebral visual impairment, pituitary apoplexy, midbrain ischemia, visual pseudohallucinations, Horner syndrome, endophthalmitis, supranuclear ocular motility disorders, and orbital hemorrhage. Less recognized potential complications included ocular hypotony, amaurosis fugax, chiasmal stroke, Miller Fisher syndrome, ocular ischemic syndrome, paracentral acute middle maculopathy, and retinal detachment. Based on case report data, patients were predominantly men and most often in their 6th or 7th decades of life, ischemic optic neuropathy accounted for the most events, and coronary artery bypass grafting was the most frequently implicated operation. Recurring perioperative associations with cardiopulmonary bypass, hemodynamic instability, embolic phenomena, anemia, and preexisting vascular comorbidities were observed across studies. Visual outcomes were variable, with many ischemic complications resulting in persistent deficits. Conclusions: Ocular and visual complications after cardiac surgery constitute a broad, heterogeneous group of disorders that, albeit rare, may result in substantial morbidity. Clinical awareness, perioperative vigilance, and prompt multidisciplinary evaluation may facilitate early identification and timely management.